Rare APOE missense variants V236E and R251G associated with substantial reduction in risk of Alzheimer disease
1. APOE ε3 (V236E) and APOE ε4 (R251G), 2 rare missense genetic variants, both had a substantial...
Read MoreJun 3, 2022
1. APOE ε3 (V236E) and APOE ε4 (R251G), 2 rare missense genetic variants, both had a substantial...
Read MoreJun 2, 2022
1. Among a group of risky drinkers seeking online help in Sweden, a digital alcohol intervention...
Read MoreJun 2, 2022
1. A decline in gait speed paired with domain-specific cognitive decline proved to be strongly...
Read MoreJun 2, 2022
1. The control group (debridement-only) reported better clinical outcomes at 12 months compared to...
Read MoreJun 2, 2022
1. Using a stepwise, interdisciplinary approach, an algorithm was developed to improve the rates...
Read MoreJun 2, 2022
1. This cohort study found that among 623,140 individuals participating in the Asia Cohort...
Read MoreJun 2, 2022
1. This retrospective cohort study using the TARGet Kids! Cohort demonstrated that late and...
Read MoreMay 30, 2022
1. In this systematic review and meta-analysis, medical cannabis and cannabinoids versus placebo...
Read MoreMay 27, 2022
1. This systematic review and meta-analysis demonstrated that the onset of Alzheimer disease in...
Read MoreMay 26, 2022
1. Select features distinguish early-onset Lewy Body Dementia from early-onset Alzheimer dementia,...
Read MoreMay 26, 2022
1. Fewer composite cardiovascular events were seen in patients on a Mediterranean diet compared to...
Read MoreMay 25, 2022
1. 5-year progression-free status was greatest in group 3 (triple therapy) and lowest in group 1...
Read MoreMay 19, 2022
1. Cabotegravir was shown to be superior to TDF-FTC in preventing HIV infection in women. 2. Both...
Read MoreMay 18, 2022
1. Meditative therapies appear to be more beneficial for improving sleep quality, fatigue...
Read MoreMay 18, 2022
1. Complete clinical response at 6 months was similar in both the topical imiquimod and surgery...
Read MoreMay 14, 2022
1. In patients with stable chest pain and intermediate pretest probability of coronary artery...
Read MoreMay 14, 2022
1. Patients receiving the fourth dose of BNT162b2 (Pfizer-BioNTech) showed reduced rates of...
Read MoreMay 14, 2022
1. Dapagliflozin reduced the risk of worsening heart failure or cardiovascular death regardless of...
Read MoreMay 14, 2022
1. The Canadian Syncope Risk Score was superior when compared to the Osservatorio Epidemiologico...
Read MoreMay 14, 2022
1. Adding a mask recommendation to other public measures did not reduce the SARS-Cov-2 infection...
Read More